■COVID-19患者的HAI患病率在4.8%至42.8%之间,其中危重患者的发病率最高。本研究旨在评估重症和危重症COVID-19患者HAI的临床特征,它们的微生物学特征,以及可归因的风险因素。
■这是一个分析观测,回顾性单中心,纳入2020年9月至2021年2月圣乔治医院收治的723例重症COVID-19患者的队列研究。数据收集包括人口统计学变量(性别,年龄),合并症,实验室发现,HAI类型和代理商,COVID-19治疗方式,住院设置,逗留时间,和死亡率。使用SPSS版本25分析数据。
■发生HAI的患者的患病率为7.3%(723人中有53人)。追踪五种类型的医院细菌感染,注意呼吸机相关性肺炎(41.26%),导尿管相关尿路感染(28.6%),医院获得性肺炎(17.44%),导管相关性血流感染(6.35%),和血流感染(6.35%)。二元Logistic分析显示,HAI在统计学上受到四个因素的影响,注意患者的年龄(p=0.039),LengthofStay(p<0.001),BIPAP(p=0.019),机械通气(p<0.001)。在机械通气的情况下,HAI的风险增加了3.930倍,2.366倍在BIPAP的情况下,当LOS增加1天的1.148倍,年龄较高1岁时的1.029倍。
■由于HAI在重症和危重症COVID-19患者中的患病率很高,准备具有诊断性的治疗是很重要的,预防性,以及这种感染的控制措施。
The prevalence of
HAI among COVID-19 patients ranged between 4.8% and 42.8% with the highest occurrence observed in critically ill patients. The present study aimed to evaluate the clinical features of
HAI in severe and critical COVID-19 patients, their microbiological characteristics, and the attributable risk factors.
This is an analytical observational, retrospective single-center, cohort study that included 723 patients with severe-critical COVID-19 admitted to Saint George Hospital between September 2020 and February 2021. Data collection included demographic variables (sex, age), comorbidities, laboratory findings,
HAI types and agents, COVID-19 treatment modalities, hospitalization settings, length of stay, and mortality rate. Data was analyzed using SPSS version 25.
The prevalence of patients developing
HAI was 7.3% (53 of 723). Five types of nosocomial bacterial infections were tracked noting ventilator-associated pneumonia (41.26%), catheter-associated urinary tract infection (28.6%), hospital-acquired pneumonia (17.44%), catheter-related bloodstream infection (6.35%), and bloodstream infection (6.35%). Binary logistic analysis showed that
HAI are statistically affected by four factors noting patients\' age (p = 0.039), Length of Stay (p < 0.001), BIPAP (p = 0.019), and mechanical ventilation (p < 0.001). The risk of having HAI increases 3.930 times in case of mechanical ventilation, 2.366 times in case of BIPAP, 1.148 times when the LOS increases 1 day, and 1.029 times when the age is higher with 1 year.
Since the prevalence of HAI is high among severe and critical COVID-19 patients, it is important to prepare a treatment with diagnostic, preventative, and control measures for this infection.